| human | Q5 |
| P6178 | Dimensions author ID | 0604006420.49 |
| P227 | GND ID | 1071577948 |
| P2671 | Google Knowledge Graph ID | /g/11b5v4m_xw |
| P269 | IdRef ID | 156906805 |
| P213 | ISNI | 0000000077106648 |
| P244 | Library of Congress authority ID | nb2010003609 |
| P496 | ORCID iD | 0000-0001-6734-5001 |
| P7293 | PLWABN ID | 9811568965905606 |
| P10861 | Springer Nature person ID | 0604006420.49 |
| P214 | VIAF ID | 107363120 |
| P10832 | WorldCat Entities ID | E39PBJg8JRdmgHfbtPk3QPKWXd |
| P27 | country of citizenship | Germany | Q183 |
| P108 | employer | University of Duisburg-Essen | Q696757 |
| Johannes Gutenberg University Mainz | Q161982 | ||
| P734 | family name | Gerken | Q20996260 |
| Gerken | Q20996260 | ||
| Gerken | Q20996260 | ||
| P735 | given name | Guido | Q639762 |
| Guido | Q639762 | ||
| P1412 | languages spoken, written or signed | German | Q188 |
| P1559 | name in native language | Guido Gerken | |
| P106 | occupation | university teacher | Q1622272 |
| P21 | sex or gender | male | Q6581097 |
| Q64052174 | Q64052174 |
| Q41601109 | A -1573T>C SNP within the human TRAIL promoter determines TRAIL expression and HCC tumor progression |
| Q57789419 | A 13-nation population survey of upper gastrointestinal symptoms: prevalence of symptoms and socioeconomic factors |
| Q46109540 | A 55-year-old woman with thymoma and hypogammaglobulinemia (Good syndrome), ulcerative colitis, and cytomegalovirus infection |
| Q28550755 | A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases |
| Q28285520 | A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma |
| Q35075280 | A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization |
| Q45761265 | A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis |
| Q56989518 | A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection |
| Q33600495 | Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis |
| Q40678060 | Acute Liver Failure - It's Just a Matter of Cell Death. |
| Q40816631 | Acute hepatic failure: limitations of medical treatment and indications for liver transplantation |
| Q39900226 | Acute liver failure in a metropolitan area in Germany: a retrospective study (2002 - 2008). |
| Q54356292 | Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. |
| Q35565411 | Acute liver failure: a life-threatening disease. |
| Q51440237 | Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents. |
| Q41462634 | Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure. |
| Q54410050 | Addition of diffusion-weighted imaging can improve diagnostic confidence in bowel MRI. |
| Q30367298 | Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients. |
| Q39914709 | Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C. |
| Q34151453 | Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study |
| Q35788567 | All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells |
| Q42202767 | All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study |
| Q94467522 | Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC |
| Q57205190 | Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon |
| Q35214136 | Altered expression of SHIP, a Toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infection |
| Q46804315 | An ex vivo perfusion system emulating in vivo conditions in noncirrhotic and cirrhotic human liver. |
| Q39259431 | Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders |
| Q57205202 | Angiosarkom der Leber als seltene Ursache eines rasch progredienten Leberversagens |
| Q42982616 | Anti-GOR and hepatitis C virus in autoimmune liver diseases |
| Q50753509 | Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity. |
| Q57205209 | Antiviral treatment of chronic hepatitis B with lamivudine in pediatric renal transplantation |
| Q40386531 | Aortoesophageal fistula after thoracic aortic stent-graft placement: a rare but catastrophic complication of a novel emerging technique |
| Q35728531 | Aortoesophageal fistula secondary to stent-graft repair of the thoracic aorta |
| Q36298426 | Apoptosis and fibrosis in non-alcoholic fatty liver disease. |
| Q37749319 | Apoptosis in immune-mediated liver diseases |
| Q37612987 | Apoptosis in selected liver diseases. |
| Q57205163 | Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis |
| Q46629618 | Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute-on-chronic liver failure. |
| Q43244168 | Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome |
| Q47660970 | Asialoglycoprotein receptor facilitates hemolysis in patients with alcoholic liver cirrhosis |
| Q45853311 | Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S- and S-encoded viral surface antigens |
| Q43119562 | Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients |
| Q45776652 | Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis |
| Q40394229 | Autoimmune Hepatitis and Hepatitis C Virus Infection |
| Q51297544 | Balloon dilatation vs. balloon dilatation plus bile duct endoprostheses for treatment of anastomotic biliary strictures after liver transplantation. |
| Q42199556 | Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells |
| Q52527134 | Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. |
| Q38003970 | Biliary complications after liver transplantation: addition of T1-weighted images to MR cholangiopancreatography facilitates detection of cast in biliary cast syndrome |
| Q57205203 | Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis |
| Q43030525 | Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial |
| Q34094106 | Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C. |
| Q35739182 | Biological standards for hepatitis B virus assays |
| Q44131260 | CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling |
| Q96428697 | CTLA-4 Expression Plays a Role in PSC and PBC Progression |
| Q54390055 | Campylobacter jejuni-induced severe colitis--a rare cause of toxic megacolon. |
| Q43979351 | Capsaicin-sensitive nerve fibres induce epithelial cell proliferation, inflammatory cell immigration and transforming growth factor-alpha expression in the rat colonic mucosa in vivo |
| Q44085470 | Cardiac manifestations in HIV-infected individual |
| Q40495834 | Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients - part III: age differences. |
| Q44848082 | Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: gender differences. |
| Q88519970 | Challenges in Liver Transplantation |
| Q39225838 | Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals |
| Q41924153 | Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro |
| Q42002544 | Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma |
| Q55223622 | Cholesteryl Ester Storage Disease: Fatal Outcome without Causal Therapy in a Female Patient with the Preventable Sequelae of Progressive Liver Disease after Many Years of Mild Symptoms. |
| Q42985654 | Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-alpha therapy |
| Q52895986 | Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha. |
| Q89835733 | Clinical and functional patient characteristics predict medical needs in older patients at risk of functional decline |
| Q40157005 | Clinical course and core variability in HBV infected patients without detectable anti-HBc antibodies |
| Q44482188 | Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay |
| Q42978979 | Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA. |
| Q59352380 | Clinical outcome and viral genome variability of hepatitis B virus induced acute liver failure (HEP-18-0579) |
| Q40047815 | Clinical patterns associated with the concurrent detection of anti-HBs and HBV DNA. |
| Q54220908 | Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure. |
| Q46943584 | Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoring |
| Q34966525 | Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency |
| Q46109545 | Collateral damage of cephalosporins and quinolones and possibilities for control |
| Q43283959 | Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized study |
| Q30940119 | Combined small and large bowel MR imaging in patients with Crohn's disease: a feasibility study |
| Q35788690 | Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium |
| Q57205165 | Comparison of different MRCP techniques for the depiction of biliary complications after liver transplantation |
| Q36484946 | Comparison of the sixth and the seventh editions of the UICC classification for perihilar cholangiocarcinoma |
| Q35082408 | Concomitant interferon alpha stimulation and TLR3 activation induces neuronal expression of depression-related genes that are elevated in the brain of suicidal persons |
| Q57771632 | Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure |
| Q57079480 | Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state |
| Q47547092 | Course of hepatitis E infection in a patient with rheumatoid arthritis and autoimmune hepatitis: A case report |
| Q46973719 | Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure |
| Q42995589 | Cryoglobulin-associated uptake of hepatitis C virus into human hepatocytes. |
| Q46592607 | Current concepts for prophylaxis and treatment of hepatitis B virus reinfection after liver transplantation |
| Q42104230 | Cyclosporine A, FK-506, 40-0-[2-hydroxyethyl]rapamycin and mycophenolate mofetil inhibit proliferation of human intrahepatic biliary epithelial cells in vitro |
| Q33788431 | Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis |
| Q45832527 | Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. |
| Q36373301 | Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C. |
| Q34812028 | DNA-based immunotherapy: potential for treatment of chronic viral hepatitis? |
| Q41208475 | Daclatasvir, Simeprevir and Ribavirin as a Promising Interferon-Free Triple Regimen for HCV Recurrence after Liver Transplant |
| Q50582340 | Daily interferon Alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection |
| Q42190321 | Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant |
| Q47736723 | Dark-lumen magnetic resonance colonography in patients with suspected sigmoid diverticulitis: a feasibility study |
| Q57205195 | Das hepatorenale Syndrom |
| Q41506685 | Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable |
| Q34415922 | Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice |
| Q57205145 | Detection of biliary stenoses in patients after liver transplantation: Is there a different diagnostic accuracy of MRCP depending on the type of biliary anastomosis? |
| Q40423473 | Detection of circulating autoantibodies directed against the asialoglycoprotein receptor using recombinant receptor subunit H1. |
| Q44539045 | Detection of hepatitis B virus markers in sera of asymptomatic hepatitis B surface antigen carriers with special emphasis to pre-S-encoded proteins |
| Q42991405 | Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum |
| Q43041721 | Detection of hepatitis C virus replication in ovarian metastases of a patient with hepatocellular carcinoma |
| Q45275914 | Detection of pre-S gene products in HBsAg carriers and in hepatitis B vaccines |
| Q57205224 | Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver |
| Q54085100 | Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease -- possible association with a steroid-resistant transplant rejection episode. |
| Q35010323 | Diagnosis of biliary strictures after liver transplantation: which is the best tool? |
| Q43525869 | Diagnosis of tuberculosis infection in patients awaiting liver transplantation. |
| Q42019263 | Diagnostic Dilemma in a Patient with Jaundice: How to Differentiate between Autoimmune Pancreatitis, Primary Sclerosing Cholangitis and Pancreas Carcinoma |
| Q53218974 | Diagnostic value of diffusion-weighted imaging (DWI) for the assessment of the small bowel in patients with inflammatory bowel disease. |
| Q57205243 | Die Lebensqualität von Patienten vor und nach Nierentransplantation |
| Q57789807 | Die chronische intestinale Pseudoobstruktion - Untersuchung zur klinischen Symptomatik und Verlauf - |
| Q57205137 | Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: Is it still reliable? |
| Q44452954 | Distinction between natural and pathological autoantibodies by immunoblotting and densitometric subtraction: liver-kidney microsomal antibody (LKM) positive sera identify multiple antigens in human liver tissue. |
| Q57789562 | Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission |
| Q43923619 | Diurnal variation of abdominal motor responses to colorectal distension and plasma cortisol levels in rats |
| Q28194057 | Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? |
| Q53666805 | Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI. |
| Q45936266 | Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients. |
| Q44166636 | Effect of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension |
| Q51367835 | Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. |
| Q44089673 | Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial |
| Q46843883 | Efficacy of C0 and C2 monitoring in adult liver transplant recipients treated with neoral, mycophenolate mofetil, and steroids |
| Q44751211 | Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation |
| Q57205229 | Efficacy of transarterial chemoembolization prior to liver transplantation for hepatocellular carcinoma as found in pathology |
| Q57205151 | Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation |
| Q57205140 | Elevated gamma-glutamyltransferase is associated with mortality in lung transplantation for cystic fibrosis |
| Q45756883 | Endoscopic management is the treatment of choice for bile leaks after liver resection |
| Q51325255 | Endoscopic therapy of posttransplant biliary stenoses after right-sided adult living donor liver transplantation. |
| Q41643135 | Endoscopic treatment of pediatric post-transplant biliary complications is safe and effective |
| Q90183222 | Enzymatic liver function measured by LiMAx - a reliable diagnostic and prognostic tool in chronic liver disease |
| Q40770690 | Epithelial cell-derived components induce transforming growth factor-alpha mRNA expression and epithelial cell proliferation in vitro |
| Q45360969 | Etiologies and outcomes of acute liver failure in Germany. |
| Q35101419 | Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients |
| Q43039606 | Evaluation of different serum RNA extraction protocols using quantitative HCV-PCR. |
| Q35959053 | Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy |
| Q50528476 | Excessive bilirubin elevation in a patient with hereditary spherocytosis and intrahepatic cholestasis. |
| Q54178252 | Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center. |
| Q50524213 | Expression of Fibrogenic Markers in Tumor and Tumor-Surrounding Tissue at Time of Transplantation Correlates with Recurrence of Hepatocellular Carcinoma in Patients Undergoing Liver Transplantation. |
| Q45833115 | Expression of Pre-S-encoded proteins in sera of individuals chronically infected with hepatitis D virus |
| Q39426819 | Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinoma |
| Q43688798 | Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats |
| Q42635211 | Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration |
| Q44561660 | Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients |
| Q35575878 | FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus |
| Q44697151 | Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis |
| Q41899484 | From bedside to bench and back again-molecular mechanisms in acute liver failure |
| Q91232566 | GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis |
| Q45435713 | GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection |
| Q57789773 | Gastrokolische Fistel als seltene Ursache von Kachexie und Polyneuropathie |
| Q47821099 | Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation. |
| Q38348142 | Glutamate dehydrogenase and alkaline phosphatase as very early predictors of hepatocellular carcinoma recurrence after liver transplantation |
| Q35958948 | Glutathione-S-transferase subtypes α and π as a tool to predict and monitor graft failure or regeneration in a pilot study of living donor liver transplantation |
| Q33403401 | Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders--an evaluation study |
| Q54277226 | HBV reactivation in allogeneic stem cell transplant recipients: Risk factors, outcome, and role of hepatitis B virus mutations. |
| Q57079502 | HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines |
| Q43681134 | HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy |
| Q43037715 | HCV replication in mononuclear cells stimulates anti‐HCV‐secreting B cells and reflects nonresponsiveness to interferon‐α |
| Q51113819 | HCV-associated cryoglobulinaemia presenting with vasculitis, hepatitis, and glomerulonephritis - a therapeutic dilemma. |
| Q44275964 | HIV and pregnancy: risks of transmission and therapeutic possibilities |
| Q92620868 | Health outcome of older hospitalized patients in internal medicine environments evaluated by Identification of Seniors at Risk (ISAR) screening and geriatric assessment |
| Q44056430 | Hepatic encephalopathy |
| Q40238231 | Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice and can be induced by treatment with HBV particles or lipopolysaccharides in vitro |
| Q44611062 | Hepatic expression patterns of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B. |
| Q37279114 | Hepatitis B and liver transplantation: 2008 update |
| Q44347501 | Hepatitis B defective virus with rearrangements in the preS gene during HBV chronic infection |
| Q45854728 | Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection |
| Q36845647 | Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen |
| Q92568797 | Hepatitis B virus particles activate toll-like receptor 2 signaling initial upon infection of primary human hepatocytes |
| Q45787228 | Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment |
| Q45208404 | Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells |
| Q45758621 | Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation |
| Q44518699 | Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape |
| Q43261381 | Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae |
| Q42982272 | Hepatitis C virus (HCV) and autoimmune liver diseases |
| Q43048361 | Hepatitis C virus associated primary hepatocellular carcinoma in a noncirrhotic liver |
| Q38408888 | Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents |
| Q38254120 | Hepatitis C-associated liver carcinogenesis: role of PML nuclear bodies |
| Q38386699 | Hepatitis E Virus Infection as a Possible Cause of Acute Liver Failure in Europe. |
| Q95938167 | Hepatocyte KLF6 expression affects FXR signalling and the clinical course of primary sclerosing cholangitis |
| Q45138566 | High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome |
| Q35684045 | Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure. |
| Q112611670 | Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection |
| Q91510710 | How to Define Acute Liver Failure Patients with Pre-Existing Liver Disease without Signs of Cirrhosis |
| Q86702600 | How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? |
| Q37195557 | Human Ex-Vivo Liver Model for Acetaminophen-induced Liver Damage |
| Q40122217 | Hybrid imaging of the bowel using PET/MR enterography: Feasibility and first results |
| Q39035030 | Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication |
| Q55301858 | IgG4-Associated Inflammatory Pseudotumor with Bilobar Hepatic Foci. |
| Q43985422 | Immune blot analysis of viral surface proteins in serum and liver of patients with chronic hepatitis B virus infection |
| Q92264831 | Immunoglobulin G4-Related Pancreatitis: Our Experience in a German Cohort of 59 Patients |
| Q47409507 | Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplant |
| Q42989759 | Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action |
| Q51765808 | Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection. |
| Q36391815 | Impact of Liver Indicators on Clinical Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation |
| Q47786935 | Impact of a self-expanding, plastic esophageal stent on various esophageal stenoses, fistulas, and leakages: a single-center experience in 39 patients |
| Q44024744 | Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study |
| Q56967183 | Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany |
| Q51894777 | Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety. |
| Q51032454 | Improved detection of inflammatory bowel disease by additional automated motility analysis in magnetic resonance imaging. |
| Q36581177 | In Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter. |
| Q38984450 | In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? |
| Q43036194 | In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C |
| Q45961434 | Increased expression of epidermal growth factor-receptor in an experimental model of colitis in rats. |
| Q40285334 | Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma |
| Q40494233 | Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets |
| Q40951582 | Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells |
| Q51838498 | Interferon-alpha differentially affects homeostasis of human plasmacytoid and myeloid dendritic cells. |
| Q40969500 | Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment |
| Q41006807 | Interferon-alpha retreatment in chronic hepatitis C |
| Q42990093 | Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells |
| Q45355031 | Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1. |
| Q50582911 | Interleukin-2 has no additional therapeutic efficacy in the retreatment of patients with chronic hepatitis C that had not responded to interferon-alpha plus ribavirin. |
| Q53092822 | Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia? |
| Q57205155 | Klinik und Diagnostik der Hepatitiden B, C und D. Akuter oder chronischer Verlauf? |
| Q40093274 | Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury |
| Q40393165 | Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study |
| Q50126990 | Liberal policy in living donor liver transplantation for hepatocellular carcinoma: lessons learned. |
| Q44179322 | Lisofylline and lysophospholipids ameliorate experimental colitis in rats |
| Q26740326 | Liver Failure due to Acute Viral Hepatitis (A-E) |
| Q35250192 | Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome. |
| Q57045594 | Liver Maximum Capacity: A Novel Test to Accurately Diagnose Different Stages of Liver Fibrosis |
| Q88315961 | Liver Regeneration-Related Cytokine Profiles in Donors and Recipients Before and After Living-Donor Liver Transplant |
| Q43048571 | Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia |
| Q36720361 | Liver cirrhosis associated with heterozygous alpha-1-antitrypsin deficiency type Pi MS and autoimmune features |
| Q55348506 | Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: a case report. |
| Q89687399 | Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction |
| Q53531733 | Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients. |
| Q39002754 | Liver transplantation from HCV RNA-positive donors in the era of interferon-free HCV therapeutics: a re-examination of the situation |
| Q44455371 | Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience. |
| Q44451372 | Liver transplantation--an update |
| Q44202012 | Liver-infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance. |
| Q57205207 | Living donor liver transplantation for hepatocellular carcinoma: A single-center preliminary report |
| Q57205239 | Living-related liver transplantation from the view of the donor: a 1-year follow-up survey |
| Q44087248 | Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients |
| Q44781592 | Long-term effects of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension |
| Q41931578 | Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens |
| Q44162909 | Long-term follow-up of patients with chronic hepatitis B after interferon treatment |
| Q42980090 | Long-term follow-up of patients with chronic hepatitis C after interferon-alpha treatment |
| Q43645710 | Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience |
| Q42223356 | Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatment |
| Q36206134 | Long-term therapy of a patient with summerskill-walshe-tygstrup syndrome by applying prometheus® liver dialysis: a case report |
| Q34342336 | Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis |
| Q92473438 | Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis |
| Q28540768 | Low levels of blood lipids are associated with etiology and lethal outcome in acute liver failure |
| Q39008596 | Low transferrin and high ferritin concentrations are associated with worse outcome in acute liver failure. |
| Q47409180 | Low-molecular-weight heparin in patients with advanced cirrhosis |
| Q28248437 | MHC class II genes influence the susceptibility to chronic active hepatitis C |
| Q31042771 | MR colonography for the assessment of colonic anastomoses |
| Q40210148 | MR colonography vs. optical colonoscopy: comparison of patients' acceptance in a screening population |
| Q46472633 | MR-guided liver biopsy within a short, wide-bore 1.5 Tesla MR system |
| Q57205148 | Magnetic endoscopic imaging saves abdominal compression and patient pain in routine colonoscopies |
| Q31104518 | Magnetic resonance colonography without bowel cleansing: a prospective cross sectional study in a screening population |
| Q50590704 | Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. |
| Q85291030 | Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis |
| Q35626794 | Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant |
| Q34529938 | MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer |
| Q53662251 | Mini-laparoscopy guided liver biopsy increases diagnostic accuracy in acute liver failure. |
| Q38839103 | Monitoring of endoscope reprocessing with an adenosine triphosphate (ATP) bioluminescence method |
| Q38976828 | Morbidity and Mortality Rounds in Liver Transplantation |
| Q51125484 | Motility mapping as evaluation tool for bowel motility: initial results on the development of an automated color-coding algorithm in cine MRI. |
| Q45780299 | Mutation specific PCR and direct solid phase sequencing assay for the detection of hepatitis B virus pre-C/C mutants in anti-HBe-positive, chronic hepatitis B. |
| Q32059658 | Mycophenolate mofetil reduces tissue damage and inflammation in an experimental model of colitis in rats |
| Q43288507 | Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells |
| Q38888503 | Mycophenolic acid induces apoptosis of hepatic stellate cells in an in vitro model of HCV. |
| Q91675598 | NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization |
| Q48177846 | Neuroendocrine and blood pressure responses to rectal distensions in individuals with high and low visceral pain sensitivity |
| Q42949767 | New drugs for the treatment of constipation |
| Q43662275 | No association between mannose-binding lectin alleles and susceptibility to chronic hepatitis B virus infection in German patients |
| Q46853529 | Non-alcoholic fatty liver disease in HIV-positive patients predisposes for acute-on-chronic liver failure: two cases. |
| Q44123228 | Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. |
| Q28540257 | Non-invasive separation of alcoholic and non-alcoholic liver disease with predictive modeling |
| Q35948791 | Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort. |
| Q28289982 | Novel algorithm for non-invasive assessment of fibrosis in NAFLD |
| Q37542835 | Novel implications in the treatment of hepatocellular carcinoma |
| Q45048493 | Novel prognostic scoring system after surgery for Klatskin tumor. |
| Q40302798 | Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells |
| Q37806012 | Obesity affects the liver - the link between adipocytes and hepatocytes. |
| Q57205157 | Onset of heart failure determines the hepatic cell death pattern |
| Q50919196 | Optimized endoscopic treatment of ischemic-type biliary lesions after liver transplantation. |
| Q45514449 | Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis |
| Q37703605 | Outcome and Genetic Factors in IgG4-Associated Autoimmune Pancreatitis and Cholangitis: A Single Center Experience. |
| Q46732707 | Overweight patients are more susceptible for acute liver failure. |
| Q40383615 | Parenchymal and nonparenchymal liver cells and their interaction in the local immune response |
| Q33664268 | Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation |
| Q28301659 | Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial |
| Q37547182 | Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience |
| Q40524673 | Performance characteristics of the VERSANT hepatitis C virus RNA 1.0 (kPCR) assay |
| Q42979071 | Persistent expression of hepatitis C virus genome in primary tumor and adrenal metastasis of a hepatocellular carcinoma developed in a non-cirrhotic liver |
| Q46077926 | Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil |
| Q34601701 | Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome. |
| Q44801102 | Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection |
| Q41172935 | Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis |
| Q45786212 | Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia |
| Q52597721 | Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients. |
| Q45830695 | Pre-S encoded surface proteins in relation to the major viral surface antigen in acute hepatitis B virus infection. |
| Q45766435 | Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation |
| Q43795949 | Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta |
| Q45066153 | Predictive factors of outcome in patients transplanted for hepatitis B. |
| Q45401966 | Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation |
| Q44493797 | Pregnancy-associated Sweet's syndrome in an acute episode of ulcerative colitis |
| Q46393999 | Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. |
| Q57205222 | Preoperative donor liver biopsy for adult living donor liver transplantation: Risks and benefits |
| Q57205231 | Presence of markers for liver progenitor cells in human-derived intrahepatic biliary epithelial cells |
| Q39806632 | Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. |
| Q57789585 | Prevalence of Unexplained Upper Abdominal Symptoms in Patients with Migraine |
| Q40540365 | Proapoptotic function of protein kinase CK2alpha" is mediated by a JNK signaling cascade |
| Q57205167 | Prognostic Assessment of Three Single-Nucleotide Polymorphisms (GNB3825C>T,BCL2-938C>A,MCL1-386C>G) in Extrahepatic Cholangiocarcinoma |
| Q42609247 | Prokinetics in patients with gastroparesis: a systematic analysis |
| Q45788159 | Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e–minus hepatitis B virus mutants |
| Q42280277 | Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial |
| Q51245157 | Psychological stress and the severity of post-inflammatory visceral hyperalgesia. |
| Q40291312 | Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome |
| Q42757195 | Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension |
| Q51775204 | Quality of life and psychiatric complications after adult living donor liver transplantation. |
| Q40910985 | Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment |
| Q45755084 | Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure |
| Q43040460 | Quantitation of HCV-replication using one-step competitive reverse transcription-polymerase chain reaction and a solid phase, colorimetric detection method |
| Q40830659 | Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B. |
| Q53570446 | Quantitative assessment of small bowel motility in patients with Crohn's disease using dynamic MRI. |
| Q46947908 | Quantitative liver function tests in donors and recipients of living donor liver transplantation |
| Q57079477 | Radioembolisation bei fortgeschrittenem hepatozellulärem Karzinom |
| Q40001024 | Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries |
| Q35763616 | Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts? |
| Q51642133 | Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. |
| Q91147767 | Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial |
| Q43038810 | Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C. |
| Q42197754 | Rapid Regulation of Depression-Associated Genes in a New Mouse Model Mimicking Interferon-α-Related Depression in Hepatitis C Virus Infection |
| Q42978341 | Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin |
| Q44902829 | Rare pre-core stop-codon mutant nt. 1897 predominates over wide-spread mutant nt. 1896 in an unusual course of chronic hepatitis B. |
| Q45759858 | Receptor-mediated entry of hepatitis B virus particles into liver cells |
| Q41442218 | Recombinant human erythropoietin counteracts cisplatin-induced visceral hyperalgesia |
| Q41998036 | Recurrent lymphocytic myocarditis in a young male with ulcerative colitis |
| Q54684333 | Regulation of cytochrome P450 IID by acute phase mediators in C3H/HeJ mice |
| Q45769771 | Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection |
| Q43781215 | Relationship of pre-S encoded antigens in liver and clinical manifestations of chronic hepatitis B infection. |
| Q38489634 | Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. |
| Q45923082 | Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients. |
| Q47987646 | Rescue therapy of a refractory rectal variceal bleeding in a cirrhotic patient by Linton-Nachlas tube and TIPS implantation in combination with variceal embolization |
| Q36516635 | Resectability of hepatocellular carcinoma: evaluation of 333 consecutive cases at a single hepatobiliary specialty center and systematic review of the literature |
| Q33430547 | Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study. |
| Q24626209 | Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells |
| Q47775864 | Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation |
| Q47371867 | Right living donor liver transplantation: an option for adult patients: single institution experience with 74 patients |
| Q21245706 | Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion |
| Q46245997 | Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection |
| Q41164136 | Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice |
| Q37957971 | Role of stress-induced NKG2D ligands in liver diseases. |
| Q40099772 | Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients |
| Q48793976 | Rotational thromboelastometry can detect factor XIII deficiency and bleeding diathesis in patients with cirrhosis |
| Q49287362 | SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease |
| Q47212247 | Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience |
| Q51892632 | Selection of donors for adult living-donor liver donation: results of the assessment of the first 205 donor candidates. |
| Q39376578 | Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy |
| Q28728766 | Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy |
| Q64886819 | Self-reports on symptoms of alcohol abuse: liver transplant patients versus rehabilitation therapy patients. |
| Q45765645 | Semiquantitative assessment of pre-core stop-codon mutant and wildtype hepatitis B virus during the course of chronic hepatitis B using a new PCR-based assay |
| Q57789822 | Sensorische Funktionen des Gastrointestinaltraktes und funktionelle Magendarmerkrankungen |
| Q33648832 | Sensory neuropathy in patients with cryoglobulin negative hepatitis-C infection |
| Q44256988 | Seroconversion in patients with acute hepatitis B reinfection after liver transplantation with a combined treatment of lamivudine and hepatitis B immune globulin |
| Q45840756 | Serotoninergic and non-serotoninergic effects of two tricyclic antidepressants on visceral nociception in a rat model |
| Q51989822 | Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis. |
| Q47931175 | Serum ferritin and survival of renal transplant recipients: a prospective 10-year cohort study |
| Q34646645 | Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure |
| Q43037983 | Serum versus intrahepatic HCV RNA and liver histology |
| Q44414132 | Severe acute pancreatitis: nonsurgical treatment of infected necroses |
| Q45777233 | Significance and relevance of serum preS1 antigen detection in wild-type and variant hepatitis B virus (HBV) infections. |
| Q43036405 | Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha |
| Q44014978 | Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients |
| Q91728576 | Single-Center Retrospective Study of Clinical and Laboratory Features That Predict Survival of Patients With Budd-Chiari Syndrome After Liver Transplant |
| Q54250888 | Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. |
| Q30992640 | Small bowel hydro-MR imaging for optimized ileocecal distension in Crohn's disease: should an additional rectal enema filling be performed? |
| Q38683491 | Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study |
| Q44488949 | Specific therapy in acute liver failure |
| Q88603799 | Spleen Stiffness Differentiates Between Acute and Chronic Liver Damage and Predicts Hepatic Decompensation |
| Q40534560 | Spleen and Liver Stiffness Is Positively Correlated with the Risk of Esophageal Variceal Bleeding |
| Q57205124 | Steatosis does not impair liver regeneration after partial hepatectomy |
| Q43434328 | Steroid and ursodesoxycholic Acid combination therapy in severe drug-induced liver injury |
| Q57205199 | Strengths and weaknesses of dark-lumen MR colonography: Clinical relevance of polyps smaller than 5 mm in diameter at the moment of their detection |
| Q39519539 | Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients |
| Q42104455 | Successful photodynamic therapy for biliary papillomatosis: a case report. |
| Q51113857 | Successful sealing of benign esophageal leaks after temporary placement of a self-expanding plastic stent without fluoroscopic guidance. |
| Q47164535 | Successful treatment of cerebral aspergillosis: case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL). |
| Q42744532 | Surgical treatment of Klatskin tumor: liver resection versus transplantation. |
| Q37629465 | Surveillance and screening of primary sclerosing cholangitis |
| Q45786352 | Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection |
| Q35114570 | TLR signaling modulates side effects of anticancer therapy in the small intestine |
| Q34986938 | TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury |
| Q87578465 | TRAIL expression levels in human hepatocellular carcinoma have implications for tumor growth, recurrence and survival |
| Q45782322 | The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers |
| Q42990947 | The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome |
| Q45830455 | The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man. |
| Q45325199 | The influence of immunosuppressants on direct-acting antiviral therapy is dependent on hepatitis C virus genotype |
| Q26827770 | The interaction of hepatic lipid and glucose metabolism in liver diseases |
| Q39855775 | The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. |
| Q90280218 | The predictive performance of SAPS 2 and SAPS 3 in an intermediate care unit for internal medicine at a German university transplant center; A retrospective analysis |
| Q39992703 | The predictive performance of the SAPS II and SAPS 3 scoring systems: A retrospective analysis |
| Q42979832 | The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha |
| Q36034244 | The relationship between apoptosis and non-alcoholic fatty liver disease: an evolutionary cornerstone turned pathogenic |
| Q33365990 | The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation |
| Q39752122 | The significance of the pre-S region of the hepatitis B virus |
| Q44025461 | Therapeutic vaccination of a liver transplant recipient suffering from fulminant hepatitis B during pregnancy |
| Q53011651 | Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol. |
| Q38062681 | Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. |
| Q39246053 | Tivantinib for the treatment of hepatocellular carcinoma |
| Q28270392 | Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C |
| Q28248119 | Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer |
| Q39806543 | Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. |
| Q44030856 | Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific |
| Q57079491 | Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice |
| Q42238958 | Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen |
| Q39999219 | Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. |
| Q50116511 | Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience |
| Q60932746 | Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function |
| Q45844537 | Treatment of patients with chronic type B hepatitis and concurrent human immunodeficiency virus infection with a combination of interferon alpha and azidothymidine: a pilot study |
| Q38486362 | Treatment of split-liver recipients with poor graft function by albumin-dialysis (Mars). |
| Q34503411 | Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide tolerance |
| Q51042991 | Two cases of pancreatic tuberculosis in nonimmunocompromised patients. A diagnostic challenge and a rare cause of portal hypertension. |
| Q53502648 | Utility of dark-lumen MR colonography for the assessment of extra-colonic organs. |
| Q33387455 | Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR. |
| Q57205197 | Value of staging laparoscopy for multimodal therapy planning in esophago-gastric cancer |
| Q45893239 | Vascular endothelial growth factor improves liver regeneration and survival after 90% hepatectomy in a rat model of diet-induced steatosis |
| Q42991357 | Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up |
| Q41341283 | Virus-associated receptors for polymerized human serum albumin (RpHSA) in patients with chronic active hepatitis B treated with recombinant leukocyte A interferon |
| Q42488224 | Visceral pain and public speaking stress: neuroendocrine and immune cell responses in healthy subjects |
| Q39467879 | Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2. |
| Q53264260 | Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. |
| Q45076991 | Volumetric and functional recovery of the liver after right hepatectomy for living donation |
| Q38976820 | When and How to Treat HCV Infection with the New Antivirals before or after Liver Transplantation |
| Q33983917 | Which patients benefit from hemodialysis therapy in hepatorenal syndrome? |
| Q85613854 | [Diagnosis and therapy of the hepatorenal syndrome] |
| Q57205213 | [Manualised group therapy concept for patients with alcoholic cirrhosis awaiting liver transplantation] |
| Q50574574 | [Recurrent disease after liver transplantation. A therapeutic dilemma or treatable?]. |
| Q57205215 | [Stabilisation of abstinence by means of psychoeducation for patients with alcoholic liver disease awaiting liver transplantation] |
| Guido Gerken | wikipedia |
Search more.